PubHawk
N Engl J Med May 2021 PMID 33999548

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.

W Schuyler Jones, Hillary Mulder, Lisa M Wruck, Michael J Pencina, Sunil Kripalani, Daniel Muñoz, David L Crenshaw, Mark B Effron, Richard N Re, Kamal Gupta, R David Anderson, Carl J Pepine, Eileen M Handberg, Brittney R Manning, Sandeep K Jain

Full text PDF Download social card

Mentions

217
Peak: 106 in May 2021
across 5 sources since May 2021

Extended reach

825,023
potential audience

Total likes

301

Video views

35

Mentions per month

May 2021 – Mar 2025

Where it's discussed

  • X / Twitter167 posts
  • News30 articles
  • Facebook10 posts
  • Blogs8 articles
  • YouTube2 videos

AI synopsis

What people are saying

Several posts highlight the findings of the study, such as the observation that no significant differences in cardiovascular events or bleeding complications exist between 81 mg and 325 mg doses of aspirin. Phrases like 'substantial switching' and 'equally safe and effective' reflect a strong engagement with the findings, conveying both concern and interest in treatment practices. The tone is predominantly analytical and constructive, indicating the community’s intent to apply the study’s insights to clinical practice.

AgreementModerate agreement

Many posts reflect a general agreement about the study’s conclusions and its relevance to treatment decisions.

InterestHigh interest

There is a high level of curiosity and eagerness to discuss the article, particularly regarding its implications for aspirin dosing.

EngagementHigh engagement

Discussions delve into specific study findings, including patient experiences and broader implications of dose switching.

ImpactHigh impact

The publication is perceived to have a significant influence on current practices and future research in cardiovascular treatment.

Abstract in brief

  • The study aimed to determine the optimal dose of aspirin (81 mg vs. 325 mg) for patients with existing atherosclerotic cardiovascular disease to reduce the risk of death, heart attacks, and strokes while assessing safety concerning major bleeding.
  • Over 15,000 patients were monitored for about 26 months, revealing that the incidence of major health events was similar between the two doses (7.28% for 81 mg and 7.51% for 325 mg).
  • The trial found a higher rate of patients switching from the higher dose to the lower dose, indicating preference or tolerability issues, with only minor differences in safety outcomes for major bleeding.
Read the full abstract

Top posts

Most liked on X and Bluesky
真鍋晋@心臓外科医
@Susumu_Manabe · X

アスピリンは81mgでも325mgでも心血管イベント予防効果に差はない。15,076例を対象にした無作為化比較試験の結果。 https://t.co/WmrSN5DNI7 https://t.co/rw3D77oY9T

May 20, 2021 · 26 likes · 5 shares · 2,337 followers View post →
AshuJadhav
@AshuPJadhav · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

May 15, 2021 · 21 likes · 5 shares · 17,556 followers View post →
Mauricio Ambriz
@AmbrizMau · X

En este ensayo pragmático de pacientes con enfermedad cardiovascular establecida, hubo un cambio sustancial de dosis a 81 mg de aspirina al día y no hubo diferencias en eventos cardiovasculares o hemorragia entre los asignados a 81 mg y 325 mg al día. DOI: 10.1056/NEJMoa2102137 https://t.co/7awL1LWssq

May 29, 2021 · 20 likes · 3 shares · 71,516 followers View post →
The Heart
@ZHeart11768530 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial via @DiabetesCareADA

Jan 8, 2024 · 19 likes · 7 shares · 32,789 followers View post →
Ami Bhatt, MD
@AmiBhattMD · X

Small but fierce: Does 81mg win? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/vdBA2cLpYs @pnatarajanmd @hmkyale @keaglemd @DLBHATTMD @ACCinTouch @rwyeh @MGHHeartHealth @NEJM

May 20, 2021 · 18 likes · 3 shares · 10,031 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！
@syuichiao89 · X

アスピリン1日81 mgに割り付けられた患者とアスピリン1日325 mgに割り付けられた患者との間で，心血管イベントや大出血に有意な差は認められなかった Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/4GrEktyPbE

May 19, 2021 · 18 likes · 1 share · 8,605 followers View post →

All mentions

Albert Kagina Sinyigaya
@DrSinyigaya · X

What are the reasons Aspirin 325 mg might be chosen for cardiovascular risk reduction over Aspirin 81 mg ? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial - PMC https://t.co/jRwH2wxASF

Mar 25, 2025 · 489 followers View post →
Oh Hahm Ma
@ohmahahm · X

RT @cruxmal88: @ohmahahm 드실거면 low dose aspirin 을 드셔야지, 저렇게 high dose는 심혈관 질환/뇌경색 예방 dose 가 아닙니다. https://t.co/ftaV6sBFk3

Feb 8, 2025 · 1 share · 45,528 followers View post →
크로이와88
@cruxmal88 · X

@ohmahahm 드실거면 low dose aspirin 을 드셔야지, 저렇게 high dose는 심혈관 질환/뇌경색 예방 dose 가 아닙니다. https://t.co/ftaV6sBFk3

Feb 8, 2025 · 6 likes · 1 share · 511 followers View post →
SID Italia
@Sid_Italia · X

Journal Club SID Basta un poco di... aspirina - A cura di Mariella Baldassarre e Gloria Formoso https://t.co/Vtz62reJmM

Jan 24, 2024 · 4 likes · 568 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 10, 2024 · 7 shares · 3,175 followers View post →
Carlos Díaz
@crdr24 · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 9, 2024 · 7 shares · 533 followers View post →
PpandeloF1
@PpandeloF · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 9, 2024 · 7 shares · 1,749 followers View post →
Aurora Issa
@AuroraIssa7 · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 9, 2024 · 7 shares · 31 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 8, 2024 · 7 shares · 856 followers View post →
Catherine J. Goodenough
@cathgoodenough · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 8, 2024 · 7 shares · 688 followers View post →
Sintayehu Abebe
@sinta_gf · X

RT @ZHeart11768530: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the…

Jan 8, 2024 · 7 shares · 452 followers View post →
The Heart
@ZHeart11768530 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial via @DiabetesCareADA

Jan 8, 2024 · 19 likes · 7 shares · 32,789 followers View post →
Diabetes Care, a research journal of the ADA
@DiabetesCareADA · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 8, 2024 · 7 shares · 3,175 followers View post →
Henry Gaviria
@henrygav5 · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 7, 2024 · 7 shares · 256 followers View post →
Alejandra Fernández
@AleFer_endo · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 7, 2024 · 7 shares · 720 followers View post →
Carlos Palacio
@CAPE1223 · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 7, 2024 · 7 shares · 1,031 followers View post →
fausto heredia z.
@drfherediaz · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 7, 2024 · 7 shares · 4,362 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @cristinatejerap: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of th…

Jan 7, 2024 · 7 shares · 1,002 followers View post →
Cristina Tejera
@cristinatejerap · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial via @DiabetesCareADA

Jan 7, 2024 · 10 likes · 7 shares · 11,491 followers View post →
Y Kano
@ykano21 · X

アスピリン 81mgと325mgで二次予防アウトカムに違いはなし https://t.co/6l7ygZyMbh

Dec 29, 2023 · 1,542 followers View post →
Marco Gómez
@MarcoGomezMD · X

Este ensayo clínico aleatorizado en JAMA arrojó que la aspirina con recubrimiento entérico no es significativamente menos efectiva en prevención de IM o AVC, pero tampoco es significativamente más segura en términos de riesgo de sangrado. #TuitMédico https://t.co/csqQqGxIVb

Oct 10, 2023 · 15,142 followers View post →
Cleveland Clinic Vascular Medicine
@ccfvascmed · X

There seems to be an outdated trend of using high-dose aspirin instead of 81 mg aspirin, especially for the purposes of secondary prevention. Why expose a patient to far greater side effects with the no additional antithrombotic effect? https://t.co/LvT7KskejH

Aug 16, 2023 · 2 likes · 521 followers View post →
Juan Pedro Romero
@JuanPedroRome20 · X

RT @javier20ch: ⬇️

Jun 4, 2023 · 3 shares · 204 followers View post →
Melissa
@Mel890101 · X

RT @javier20ch: ⬇️

Jun 3, 2023 · 3 shares · 1 followers View post →
Brayan Villamizar
@vinobra · X

RT @javier20ch: ⬇️

Jun 3, 2023 · 3 shares · 201 followers View post →
Dr. FEVI
@javier20ch · X

⬇️

Jun 3, 2023 · 11 likes · 3 shares · 13,507 followers View post →
Shobhit jadhav
@Jadhav_shobhit · X

RT @aayshacader: #ACC21 late-breakers

Jan 15, 2023 · 54 shares · 124 followers View post →
PK BSc. BMLSc. C¡s She/Her
@Pianokit · X

@giddygiddyup85 @Shambolika @publicaddress @TheFlatEartherr @SteveHodgeNZ Is aspirin experimental? It's used in clinical tray trials. https://t.co/peimtxLvcr You clearly don't know what a controlled study is, let alone a double-blind, RCT is, which is what the vaccine trials were.

Jan 11, 2023 · 1,033 followers View post →
Giuseppe Biondi-Zoccai
@gbiondizoccai · X

RT @kaulcsmc: @djc795 @cardskrish @mmamas1973 @BartoszHudzik @CMichaelGibson @drjohnm @gbiondizoccai @DrMarthaGulati @ESC_Journals @escardi…

Dec 28, 2022 · 2 shares · 12,173 followers View post →
Bartosz Hudzik MD PhD FESC FACC
@BartoszHudzik · X

RT @kaulcsmc: @djc795 @cardskrish @mmamas1973 @BartoszHudzik @CMichaelGibson @drjohnm @gbiondizoccai @DrMarthaGulati @ESC_Journals @escardi…

Dec 28, 2022 · 2 shares · 1,424 followers View post →
Sanjay Kaul
@kaulcsmc · X

@djc795 @cardskrish @mmamas1973 @BartoszHudzik @CMichaelGibson @drjohnm @gbiondizoccai @DrMarthaGulati @ESC_Journals @escardio @ehj_ed @ACCinTouch @FeliceGragnano @GiuseppeGalati_ @KardiologieHH @SABOURETCardio @DavidLBrownMD Do you think a conventional RCT (with run-in period) would have found a difference among the 2 ASA doses by minimizing switching? https://t.co/KxN0zrBQJe SAFE-PCI (stopped prematurely due to low event rates) and external generalizability! https://t.co/jZWH6uXoUF

Dec 28, 2022 · 5 likes · 2 shares · 3,259 followers View post →
TJ O’Neill
@tjoneillmd · X

@f2harrell @HiteshiKc @DavidLBrownMD @stephensenn Is this inevitable? Do you this can be overcome (to a degree) by trial designs like ADAPTABLE which functions more like “real world”? https://t.co/LRuBds0WoX

Sep 15, 2022 · 529 followers View post →
DGIM
@dgimev · X

PatientInnen mit einer #kardiovaskulären Erkrankung profitieren von #Acetylsalicylsäure (ASS). In der ADAPTABLE-Studie mit 15.076 Betroffenen waren der Nutzen und Risiko bei einer niedrigen und höheren Dosierung vergleichbar: https://t.co/kyXFW4VFOo

Jun 1, 2022 · 2,322 followers View post →
Arif Nazir
@Arif_Nazir_MD · X

RT @AMDApaltc: Dr. Sanford discusses the article, "Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease," at #PALTC22 duri…

Mar 11, 2022 · 2 shares · 545 followers View post →
john morley
@drjohnmorley · X

RT @AMDApaltc: Dr. Sanford discusses the article, "Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease," at #PALTC22 duri…

Mar 11, 2022 · 2 shares · 8,310 followers View post →
john morley
@drjohnmorley · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/sQRSrWm2hc

Mar 11, 2022 · 8,310 followers View post →
PALTmed | Post-Acute & Long-Term Care Medical Assn
@PALTmed · X

Dr. Sanford discusses the article, "Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease," at #PALTC22 during General Session II. Reference the full article: https://t.co/kZbstLWsho #PALTC22

Mar 11, 2022 · 3 likes · 2 shares · 2,950 followers View post →
MARY Aurélien
@MARYau_MCU_PH · X

@OceAlaB Le NEJM, retrouvé que remettait ce point sur le tapis. https://t.co/6zHFaqQ0xt

Mar 7, 2022 · 1 like · 1,444 followers View post →
lewk
@lucasfaley · X

A few years back I was a Research Assistant for a large, multi-site study with fairly novel methodology. I felt like I made some valuable contributions, so it's pretty cool to see it was published in the New England Journal of Medicine. https://t.co/1AMKREE2dm

Jan 7, 2022 · 5 likes · 792 followers View post →
cardio-met
@cardiomet_CE · X

32) The more recent ADAPTABLE trial (full text free at https://t.co/HGgyQxcYUr) did not find any major differences in efficacy or safety of 81 mg or 325 mg of #aspirin in terms of either #efficacy or #safety. https://t.co/HeLzOH4ktn

Dec 8, 2021 · 2 likes · 4,165 followers View post →
Maria Hazel Cohan, DNP, AGACNP-BC, AACC
@mcvhaze · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/5MD9mUA6Jn

Nov 9, 2021 · 134 followers View post →
ハム太郎@zuratomo
@zuratomo4 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/abW0Aou8yE アスピリンジレンマがないことを示したRCT

Oct 12, 2021 · 1 like · 1,462 followers View post →
Dr V K Shukla
@VinodShukla1991 · X

RT @aayshacader: #ACC21 late-breakers

Aug 28, 2021 · 54 shares · 92 followers View post →
Ken Covinsky
@geri_doc · X

325mg or 81mg per day of aspirin to prevent progressive heart disease in those with coronary disease? Study shows it does not matter--same rate of CV events and bleeding complications Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/o5l2tzWTjJ

Aug 5, 2021 · 5 likes · 9,549 followers View post →
Saber_IMSS
@Saber_IMSS · X

¿Qué diferencias significativas existen entre el cambio sustancial de dosis de aspirina en pacientes con enfermedad cardiovascular? #PersonaldeSaludIMSS, aquí te compartimos este interesante ensayo clínico

Jul 10, 2021 · 5 likes · 1 share · 16,535 followers View post →
総合診療医・家庭医masa【子育てに悩むパパ医】
@nextmasa1 · X

＃朝活 心血管疾患患者（35％MI/53％PCI既往）でアスピリン使用が81mgと325mgでどう違うか、という検証。有効性については有意差なし（全死因死亡・MI入院・脳卒中入院）。大出血の頻度も差がないが、中止・容量変更は325mgが多い。 つまり使うならば81mgでいいかも。 https://t.co/tWDcP4JsGG

Jun 21, 2021 · 2 likes · 396 followers View post →
CN1699
@Cn1699 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease #aspirin #cardiovasculardisease #casestudy #articles #journals For more information | ⬇️ https://t.co/bWLCIcnSSj https://t.co/8htN39uYKZ

Jun 15, 2021 · 729 followers View post →
Linda (Lin) Suzanne Napgezek
@LindaSN0228WI · X

RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…

Jun 11, 2021 · 118 shares · 5,884 followers View post →
Lucia Ruggiero EALR
@luciaruggiero · X

RT @GlobalPHObserv: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/I2OKhKOKRV

Jun 9, 2021 · 3 shares · 1,033 followers View post →
Equity and Health
@equityhealthdev · X

RT @GlobalPHObserv: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/I2OKhKOKRV

Jun 9, 2021 · 3 shares · 3,464 followers View post →
Culture of Health Eq
@CofHEQ · X

RT @GlobalPHObserv: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/I2OKhKOKRV

Jun 9, 2021 · 3 shares · 1,096 followers View post →
Global Health Observ
@GlobalPHObserv · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/I2OKhKOKRV

Jun 8, 2021 · 1 like · 3 shares · 6,552 followers View post →
Pitt General Internal Medicine
@PittGIM · X

In patients with cardiovascular disease, there was substantial dose switching to 81 mg of daily aspirin; no differences in cardiovascular events/bleeding between patients assigned to 81 mg or 325 mg of aspirin daily. W/ PittGIM's @MctigueKathleen in @NEJM: https://t.co/NNbrg1BPeY https://t.co/O3awS3EkY0

Jun 7, 2021 · 9 likes · 4,648 followers View post →
Miguelandry Perez
@DrMiguelandry · X

Disponible en: https://t.co/rqJJObTSKu #drmiguelandry #articulodelasemana #medicinadeurgencias #MedicinaCritica #medicinainterna #aspirina @MedicoTactico https://t.co/TqLL79lqjo

Jun 7, 2021 · 2 likes · 564 followers View post →
Antonio Manteca
@amango30 · X

RT @RevistaMFSamfyc: Efectividad comparada de la dosificación de aspirina en la enfermedad cardiovascular https://t.co/LtcEvKtnZo PMID 3399…

Jun 7, 2021 · 1 share · 138 followers View post →
Revista MFAndalucia
@RevistaMFSamfyc · X

Efectividad comparada de la dosificación de aspirina en la enfermedad cardiovascular https://t.co/LtcEvKtnZo PMID 33999548

Jun 7, 2021 · 1 like · 1 share · 723 followers View post →
NS JAWS
@nsjaws · X

RT @Susumu_Manabe: アスピリンは81mgでも325mgでも心血管イベント予防効果に差はない。15,076例を対象にした無作為化比較試験の結果。 https://t.co/WmrSN5DNI7 https://t.co/rw3D77oY9T

Jun 5, 2021 · 5 shares · 20 followers View post →
Dr Shraboni Ghosal, PhD
@ShraboniGhosal · X

RT @krychtiukmd: #ACC21 kicking off with #ADAPTABLE, a great pragmatic trial comparing two commonly used aspirin doses in patients with est…

Jun 4, 2021 · 9 shares · 1,931 followers View post →
Carol Artigas Gomez
@cartigasg · X

RT @AshuPJadhav: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

Jun 4, 2021 · 5 shares · 629 followers View post →
Diego Gomes Trinidad
@DiegoKrusty · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

Jun 1, 2021 · 7 shares · 61 followers View post →
Özden Mirasoğlu
@OzdenMirasoglu · X

RT @SehsuvarErturk: Bugün #NEJM Kalp-damar hastalığı olan hastalarda Aspirinin farklı dozlarının (81 mg ile 325 mg) etkinliğinin ve kanama…

Jun 1, 2021 · 3 shares · 949 followers View post →
Joseph Shatzel
@Clotmaster · X

No significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily. #hematology #meded #foamed #MI #CVD #aspirin #clot https://t.co/06PeYfrrDN

May 31, 2021 · 7 likes · 1,385 followers View post →
Saludteca
@Saludteca · X

Efectividad comparativa de diferentes dosis de aspirina en enfermedad cardiovascular https://t.co/BHy3P3Cwoi resumen @fisterrae del ensayo publicado en N Engl J Med 2021; 384:1981-1990 https://t.co/PpbAE8n22J

May 31, 2021 · 1,999 followers View post →
Eliud
@draquinomf · X

RT @AmbrizMau: En este ensayo pragmático de pacientes con enfermedad cardiovascular establecida, hubo un cambio sustancial de dosis a 81 mg…

May 30, 2021 · 3 shares · 21 followers View post →
Raul Fonseca
@Rulex74c · X

RT @AmbrizMau: En este ensayo pragmático de pacientes con enfermedad cardiovascular establecida, hubo un cambio sustancial de dosis a 81 mg…

May 29, 2021 · 3 shares · 512 followers View post →
Daniel Negash, MD
@dr_negash · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/tLimw9XB4e

May 29, 2021 · 221 followers View post →
Adams CardioMD
@AdamsCardioMD · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/Q0qG0HYhdW

May 29, 2021 · 608 followers View post →
Vivien Lee MD FAAN
@VivienHLee · X

In ADAPTABLE trial of 15,076 pts with cardiovascular dz, no difference btw Asa 81 vs 325mg in outcomes (death, hospitalization for MI/stroke). High rate of dose switching tho. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/0JY9qExRqV

May 29, 2021 · 954 followers View post →
Mauricio Ambriz
@AmbrizMau · X

En este ensayo pragmático de pacientes con enfermedad cardiovascular establecida, hubo un cambio sustancial de dosis a 81 mg de aspirina al día y no hubo diferencias en eventos cardiovasculares o hemorragia entre los asignados a 81 mg y 325 mg al día. DOI: 10.1056/NEJMoa2102137 https://t.co/7awL1LWssq

May 29, 2021 · 20 likes · 3 shares · 71,516 followers View post →
john morley
@drjohnmorley · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/euDtanJyoq

May 27, 2021 · 2 likes · 8,310 followers View post →
çağatay özkan
@cozkan07 · X

RT @SehsuvarErturk: Bugün #NEJM Kalp-damar hastalığı olan hastalarda Aspirinin farklı dozlarının (81 mg ile 325 mg) etkinliğinin ve kanama…

May 27, 2021 · 3 shares · 12,954 followers View post →
南郷 栄秀／Eishu NANGO, MD, PhD
@enango · X

心血管疾患の予防にアスピリン81mgと325mgに差なし． https://t.co/SOk5Cxbowi

May 27, 2021 · 2 likes · 1 share · 3,017 followers View post →
marcus
@mwl471 · X

RT @BertrandBio: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/cRxmxxMTBU https://t.co/9ponYTLBbL

May 27, 2021 · 2 shares · 64 followers View post →
A.R. García
@air_garcia · X

Comparative Effectiveness of #Aspirin Dosing in #Cardiovascular Disease . Sin diferencias en sangrados ni eventos cardiovasculares en dosis de 81 y 325 mg https://t.co/6hksbdkEkx

May 27, 2021 · 802 followers View post →
Grupo Investigación Multidisciplinar Extremeño
@GRIMEX_ · X

https://t.co/XrskZ0X9Br

May 27, 2021 · 1 like · 360 followers View post →
Med Peds Hospitalist
@medpedshosp · X

https://t.co/SwR0SVLn7c

May 26, 2021 · 1 like · 1 share · 14,247 followers View post →
Orlando_uy
@Orlando_uy · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/4cYaqc7yku

May 26, 2021 · 1 like · 694 followers View post →
Michael Makris
@ProfMakris · X

No difference in efficacy or bleeding between 81mg and 325mg of aspirin in patients with established cardiovascular disease. Paper in tomorrow's @NEJM. https://t.co/kCBkK1eg14 https://t.co/f2H7lcP9UX

May 26, 2021 · 7 likes · 1 share · 13,898 followers View post →
Monaco
@monaco_biotech · X

RT @BertrandBio: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/cRxmxxMTBU https://t.co/9ponYTLBbL

May 26, 2021 · 2 shares · 5,815 followers View post →
Bertrand Delsuc
@BertrandBio · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/cRxmxxMTBU https://t.co/9ponYTLBbL

May 26, 2021 · 6 likes · 2 shares · 18,791 followers View post →
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/OsywToRvxz

May 26, 2021 · 2,718 followers View post →
安西英雄
@deoanzai · X

心血管疾患の患者1万5,000例を対象に、アスピリンの低用量（81mg/日）と高用量（325mg/日）の比較試験を実施。心血管イベントおよび大出血のリスクに関して、両群で有意差がなく、長期アドヒアランスは低用量群で良好だった。 https://t.co/vIxaq09nOG

May 25, 2021 · 1 like · 864 followers View post →
Advarra
@advarra · X

A recent study shows taking aspirin in high or low doses can lower the chances of suffering a heart attack or stroke for those with cardiovascular disease. https://t.co/qygCjAWZBk

May 25, 2021 · 1 like · 1,314 followers View post →
Klever Diniz Barbosa
@klevermd333 · X

Os autores concluíram que nenhuma diferença significativa foi observada em desfechos clínicos ou sangramento entre pacientes com 81mg ou 325mg de AAS e que substancial troca para a dose de 81mg ocorreu durante o seguimento do estudo. Referência: DOI: 10.1056/NEJMoa2102137.

May 25, 2021 · 58 followers View post →
永添泰子(性暴力から子ども達を守る社会に変えよう)
@packraty · X

RT @uchida_kawasaki: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease - PubMed https://t.co/996sZBxz7g

May 25, 2021 · 1 share · 10,359 followers View post →
内田
@uchida_kawasaki · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease - PubMed https://t.co/996sZBxz7g

May 25, 2021 · 1 share · 1,932 followers View post →
Last Week in Medicine
@lastweekinmed · X

In patients with CV disease, there was no difference in death, hospitalization for MI, or hospitalization for stroke in patients taking 81 mg vs 325 mg. Patients assigned to 325 mg had a higher incidence of dose switching than those assigned to 81 mg. https://t.co/94sFUOaAYg

May 24, 2021 · 865 followers View post →
Dr Raul Hera Jimenez
@rhj_74 · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

May 24, 2021 · 7 shares · 701 followers View post →
Federico Castillo Álvarez
@fedefedeson · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

May 23, 2021 · 7 shares · 6,675 followers View post →
Mohamad Saud Alzayed
@K1400Tiger · X

RT @87HISHAM: كشفت نتائج الدراسة المنتظرة: ADAPTABLE Trial Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease ووجدت:…

May 23, 2021 · 3 shares · 571 followers View post →
Dídac Martí
@DidacMD11 · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

May 23, 2021 · 7 shares · 374 followers View post →
Jose Daniel Mosquera Lozano
@jdmosqueral · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

May 23, 2021 · 7 shares · 233 followers View post →
J. Vicente Esteban
@Vicenvallaurg1 · X

RT @jvillacastin: Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovas…

May 23, 2021 · 7 shares · 1,239 followers View post →
Julian P Villacastin
@jvillacastin · X

Dosis baja, mejor! In patients with established cardiovascular disease, there was no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily. https://t.co/T82zZ60g2i

May 23, 2021 · 11 likes · 7 shares · 23,374 followers View post →
Ahmed
@Ahmed92031359 · X

RT @Derek_Leong_RPh: ADAPTABLE trial: In Pts with CAD, no difference between ASA 81 mg/d and 325 mg/d for all-cause death/MI/stroke or majo…

May 23, 2021 · 1 share · 38 followers View post →
Derek Leong
@Derek_Leong_RPh · X

ADAPTABLE trial: In Pts with CAD, no difference between ASA 81 mg/d and 325 mg/d for all-cause death/MI/stroke or major bleeding at 26.2 months. More discontinuation and dose switching to 81 mg/d in the 325 mg/d group. https://t.co/q8qD2ffxtF https://t.co/hSDuhxPKVF

May 22, 2021 · 12 likes · 1 share · 1,560 followers View post →
Gladys Bendahan B
@gladysben · X

RT @rafabravo: Pues parece que lo de los 300 mg de aspirina no son necesarios. https://t.co/t5gUNkNtBW Mira que ha costado convencer a alg…

May 22, 2021 · 3 shares · 160 followers View post →
Thomas Jared Bunch
@TJaredBunch · X

RT @DrSamuelBrown: Pragmatic trials are important to do and require considerable work to interpret. That's okay. Proud that @Research_Inter…

May 21, 2021 · 3 shares · 6,750 followers View post →
Taher Bin Sumait
@Taher_Sumait · X

RT @kaz_yos: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/CKeARbvuRT https://t.co/76Aj2xITRn

May 21, 2021 · 1 share · 602 followers View post →
Dr Shraboni Ghosal, PhD
@ShraboniGhosal · X

RT @DrSamuelBrown: Pragmatic trials are important to do and require considerable work to interpret. That's okay. Proud that @Research_Inter…

May 21, 2021 · 3 shares · 1,931 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

RT @DrSamuelBrown: Pragmatic trials are important to do and require considerable work to interpret. That's okay. Proud that @Research_Inter…

May 21, 2021 · 3 shares · 9,791 followers View post →
Kirk Knowlton, MD
@KirkKnowlton · X

RT @DrSamuelBrown: Pragmatic trials are important to do and require considerable work to interpret. That's okay. Proud that @Research_Inter…

May 21, 2021 · 3 shares · 436 followers View post →
Samuel Brown
@DrSamuelBrown · X

Pragmatic trials are important to do and require considerable work to interpret. That's okay. Proud that @Research_Inter and @KirkKnowlton were able to contribute to this important effort. https://t.co/vf8O5fKm3N

May 21, 2021 · 4 likes · 3 shares · 3,722 followers View post →
Kazuki Yoshida
@kaz_yos · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/CKeARbvuRT https://t.co/76Aj2xITRn

May 21, 2021 · 4 likes · 1 share · 5,592 followers View post →
NoGracias
@nogracias_eu · X

RT @rafabravo: Pues parece que lo de los 300 mg de aspirina no son necesarios. https://t.co/t5gUNkNtBW Mira que ha costado convencer a alg…

May 21, 2021 · 3 shares · 9,606 followers View post →
UtaMariaBellin
@drutabemd · X

RT @EricTopol: New @NEJM #ACC21 What's the right dose of aspirin for people with heart disease? A large randomized trial with a lot of cro…

May 21, 2021 · 118 shares · 593 followers View post →
ときヲ
@toki_wo_koe · X

RT @Susumu_Manabe: アスピリンは81mgでも325mgでも心血管イベント予防効果に差はない。15,076例を対象にした無作為化比較試験の結果。 https://t.co/WmrSN5DNI7 https://t.co/rw3D77oY9T

May 20, 2021 · 5 shares · 2,587 followers View post →
Seigo Izumo
@SeigoIzumo · X

RT @Susumu_Manabe: アスピリンは81mgでも325mgでも心血管イベント予防効果に差はない。15,076例を対象にした無作為化比較試験の結果。 https://t.co/WmrSN5DNI7 https://t.co/rw3D77oY9T

May 20, 2021 · 5 shares · 4,021 followers View post →
真鍋晋@心臓外科医
@Susumu_Manabe · X

アスピリンは81mgでも325mgでも心血管イベント予防効果に差はない。15,076例を対象にした無作為化比較試験の結果。 https://t.co/WmrSN5DNI7 https://t.co/rw3D77oY9T

May 20, 2021 · 26 likes · 5 shares · 2,337 followers View post →
Dirk Westermann
@dirkwestermann · X

RT @AmiBhattMD: Small but fierce: Does 81mg win? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.c…

May 20, 2021 · 3 shares · 1,613 followers View post →
María Moral
@twittmariamoral · X

RT @osmachope: No hay diferencia en seguridad y resultados entre AAS 81 y 325mg @NEJM https://t.co/wH8hdLM8XC

May 20, 2021 · 3 shares · 856 followers View post →
Prof. Pedro Amariles, PhD Farmacia (farmacología)
@Pedro_AmarilesM · X

Dosis de aspirina en prevención secundaria. Estudio clínico aleatorizado pragmático (condiciones de mundo real). En pacientes con ECV aterosclerótica establecida, 81 mg/día de tiene eficacia similar a 325 mg/día; pero adherencia es mayor con 81 mg/día. En: https://t.co/zx7Uzne0s5

May 20, 2021 · 1 like · 542 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @AmiBhattMD: Small but fierce: Does 81mg win? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.c…

May 20, 2021 · 3 shares · 32,510 followers View post →
Frederick Berro Rivera, MD
@FredRiveraMD · X

RT @AmiBhattMD: Small but fierce: Does 81mg win? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.c…

May 20, 2021 · 3 shares · 857 followers View post →
Ami Bhatt, MD
@AmiBhattMD · X

Small but fierce: Does 81mg win? Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/vdBA2cLpYs @pnatarajanmd @hmkyale @keaglemd @DLBHATTMD @ACCinTouch @rwyeh @MGHHeartHealth @NEJM

May 20, 2021 · 18 likes · 3 shares · 10,031 followers View post →
Jordi Amblàs
@jordiamblas · X

RT @osmachope: No hay diferencia en seguridad y resultados entre AAS 81 y 325mg @NEJM https://t.co/wH8hdLM8XC

May 20, 2021 · 3 shares · 3,577 followers View post →
Oscar Macho
@osmachope · X

No hay diferencia en seguridad y resultados entre AAS 81 y 325mg @NEJM https://t.co/wH8hdLM8XC

May 20, 2021 · 6 likes · 3 shares · 3,038 followers View post →
Sandip Ghimire
@DrSandipGhimire · X

In #ADAPTABLE Trial there was no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of #aspirin daily. #NEJM #Medicos DOI: 10.1056/NEJMoa2102137

May 20, 2021 · 10 likes · 1,569 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @Office_j: 【SPRINT３年延長観察/ NEJM】 高リスクHTN 9361ランダム化、3.26年観察後、オープン化3.33年延長観察：「積極」降圧群のSBP平均は127mmHg、「通常」群は137。延長観察期間中の「積極」群「CV死亡・脳卒中・心イベント」…

May 19, 2021 · 4 shares · 14,778 followers View post →
unimusashi（N. Ashikawa）
@uni_pharmacist · X

RT @Office_j: 【SPRINT３年延長観察/ NEJM】 高リスクHTN 9361ランダム化、3.26年観察後、オープン化3.33年延長観察：「積極」降圧群のSBP平均は127mmHg、「通常」群は137。延長観察期間中の「積極」群「CV死亡・脳卒中・心イベント」…

May 19, 2021 · 4 shares · 1,337 followers View post →
Dr. Maria T DeSancho
@DrDeSancho · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/YoaWVSIV0K

May 19, 2021 · 1 like · 440 followers View post →
Inma Fernández
@Inma16 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/E7zleEW93R

May 19, 2021 · 436 followers View post →
バタシー♂
@batasearoyal · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease - PubMed https://t.co/k1sa7fxkMU

May 19, 2021 · 990 followers View post →
the paper link
@the_paper_link · X

RT @the_paper_link: Trend up+10: Jones WS, ..., Adaptable Team (N Engl J Med) __Comparative Effectiveness of Aspirin Dosing in Cardiovascu…

May 19, 2021 · 1 share · 137 followers View post →
☫кептагоп™Я☫
@kentaron1971 · X

RT @syuichiao89: アスピリン1日81 mgに割り付けられた患者とアスピリン1日325 mgに割り付けられた患者との間で，心血管イベントや大出血に有意な差は認められなかった Comparative Effectiveness of Aspirin Dosing…

May 19, 2021 · 1 share · 12,450 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！
@syuichiao89 · X

アスピリン1日81 mgに割り付けられた患者とアスピリン1日325 mgに割り付けられた患者との間で，心血管イベントや大出血に有意な差は認められなかった Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease https://t.co/4GrEktyPbE

May 19, 2021 · 18 likes · 1 share · 8,605 followers View post →
the paper link
@the_paper_link · X

Trend up+10: Jones WS, ..., Adaptable Team (N Engl J Med) __Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease__ https://t.co/JalDArwuw1

May 19, 2021 · 1 share · 137 followers View post →
Cindy Carrera
@Carrera13 · X

RT @Dra_TeraizaMesa: RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/ZrZp1bPRRV…

May 19, 2021 · 4 shares · 1,162 followers View post →
Ronita De, PhD
@dronita_de · X

RT @Dra_TeraizaMesa: RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/ZrZp1bPRRV…

May 19, 2021 · 4 shares · 1,503 followers View post →
Ambuj Kumar
@DrAmbuj · X

Less is more. @XavierPrida Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/4P4OF49OEF

May 18, 2021 · 2 likes · 360 followers View post →
Science Communication
@ScienceCommuni2 · X

RT @Dra_TeraizaMesa: RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/ZrZp1bPRRV…

May 18, 2021 · 4 shares · 2,880 followers View post →
Digital Health and Patient Safety Platform
@DHPSP · X

RT @Dra_TeraizaMesa: RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/ZrZp1bPRRV…

May 18, 2021 · 4 shares · 6,763 followers View post →
Dra. Teraiza Mesa R Cuenta Oficial ®
@Dra_TeraizaMesa · X

RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/ZrZp1bPRRV #DHPSP #Aspirin doasage #CVD

May 17, 2021 · 6 likes · 4 shares · 9,054 followers View post →
Sol Abeytua
@SolAbeytua · X

RT @AbeytuaManuel: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. Ther…

May 17, 2021 · 5 shares · 3 followers View post →
ぽららみん
@polmonare_int · X

RT @syuichiao89: アスピリンパラドクスとは

May 17, 2021 · 1 share · 757 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中！
@syuichiao89 · X

アスピリンパラドクスとは

May 17, 2021 · 6 likes · 1 share · 8,605 followers View post →
Dr Anthony Martin
@AMAinsight · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/t0t5D4w8xf

May 17, 2021 · 915 followers View post →
International Aspirin Foundation
@Aspirin1897 · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/DM4vR97CZV

May 17, 2021 · 388 followers View post →
Ivor Goodbody
@IvorGoodbody · X

Both low-strength (81mg per day) & regular-strength (325mg) #aspirin seem equally safe & effective in lowering risk of death, #heartattack & #stroke in patients with #heartdisease. https://t.co/aJESQeAFqP

May 17, 2021 · 1 like · 1,888 followers View post →
Pablo Avanzas
@PabloAvanzas · X

RT @AbeytuaManuel: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. Ther…

May 16, 2021 · 5 shares · 3,349 followers View post →
juan ramon
@RamonTasmania · X

RT @AbeytuaManuel: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. Ther…

May 16, 2021 · 5 shares · 96 followers View post →
Dr L Boominathan PhD
@DrLBoominathan · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/OzQ9dK38no

May 16, 2021 · 885 followers View post →
Manuel Méndez
@mendez_bailon · X

RT @AbeytuaManuel: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. Ther…

May 16, 2021 · 5 shares · 7,785 followers View post →
Orlando_uy
@Orlando_uy · X

"There was substantial dose switching to 81 mg of daily aspirin and no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily." https://t.co/owLaHOJECz

May 16, 2021 · 1 like · 694 followers View post →
Alfonso Mitre
@mitrehit · X

RT @JoseJuanatey: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM en práctica clínica no uses dosis mayores de…

May 16, 2021 · 9 shares · 287 followers View post →
Rogelio Escarpulli
@EscarpulliR · X

RT @AbeytuaManuel: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. Ther…

May 16, 2021 · 5 shares · 265 followers View post →
Manuel Abeytua
@AbeytuaManuel · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease 15,076 patients with 81 or 325 mg of aspirin. There was substantial switching to 81 mg of aspirin and no significant differences in cardiovascular events or major bleeding May15 2021 DOI: 10.1056/NEJMoa2102137 https://t.co/BjvTZdXigQ

May 16, 2021 · 6 likes · 5 shares · 617 followers View post →
Dr. Perez-Belmonte
@belmonte_dr · X

RT @JoseJuanatey: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM en práctica clínica no uses dosis mayores de…

May 16, 2021 · 9 shares · 149 followers View post →
Jose Carlos Arevalo
@joscarlor2 · X

RT @JoseJuanatey: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM en práctica clínica no uses dosis mayores de…

May 16, 2021 · 9 shares · 762 followers View post →
nobody
@NewsfeedsMedia · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM - https://t.co/xmTAWeVQJV https://t.co/L0hhgU2Nu1

May 16, 2021 · 373 followers View post →
Pedro Pablo Alcázar
@PPALCAZARR · X

RT @AshuPJadhav: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

May 16, 2021 · 5 shares · 53 followers View post →
Atanas G. Atanasov
@_atanas_ · X

RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/sq94WGnMpn #DHPSP #Aspirin doasa…

May 15, 2021 · 3 shares · 123,950 followers View post →
Science Communication
@ScienceCommuni2 · X

RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/sq94WGnMpn #DHPSP #Aspirin doasa…

May 15, 2021 · 3 shares · 2,880 followers View post →
Digital Health and Patient Safety Platform
@DHPSP · X

RT @dronita_de: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/sq94WGnMpn #DHPSP #Aspirin doasa…

May 15, 2021 · 3 shares · 6,763 followers View post →
John Heitner
@heitn001 · X

Congratulations Schuyler and team. Really well done!! Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/wTC1mZ8w8H

May 15, 2021 · 3 likes · 190 followers View post →
Jacqueline Shreibati, MD
@JShreibati · X

RT @gcfmd: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/PueukZvxTk @texhern @DCRINews @califf…

May 15, 2021 · 3 shares · 941 followers View post →
Sergio Calleja
@Montecoya · X

RT @AshuPJadhav: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

May 15, 2021 · 5 shares · 5,691 followers View post →
Alan Brown MD MHA FACC FNLA
@alanbrownmd · X

RT @gcfmd: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/PueukZvxTk @texhern @DCRINews @califf…

May 15, 2021 · 3 shares · 971 followers View post →
Dr.Bes ☤
@bosh_h · X

RT @87HISHAM: كشفت نتائج الدراسة المنتظرة: ADAPTABLE Trial Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease ووجدت:…

May 15, 2021 · 3 shares · 884 followers View post →
Rami Z. Morsi, MD
@DrRamiMorsi · X

RT @AshuPJadhav: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

May 15, 2021 · 5 shares · 1,168 followers View post →
AshuJadhav
@AshuPJadhav · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/SBW6hDsL7v

May 15, 2021 · 21 likes · 5 shares · 17,556 followers View post →
anticholium
@anticholium · X

RT @JerroldLevy: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/NEiOC84MoP

May 15, 2021 · 1 share · 101 followers View post →
Jolly Mampilly
@jollymampilly · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/0SDoYSV3o9

May 15, 2021 · 1,474 followers View post →
Lis Mendez
@lismendez · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM #ACC21 https://t.co/ua0I4arJvA

May 15, 2021 · 1,896 followers View post →
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA · X

RT @DrBenjaminHorne: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease #ADAPTABLE #ACC21 @NEJM https://t.co/5cOhHUeF94

May 15, 2021 · 9,791 followers View post →
Benjamin Horne
@DrBenjaminHorne · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease #ADAPTABLE #ACC21 @NEJM https://t.co/5cOhHUeF94

May 15, 2021 · 1 like · 1,539 followers View post →
Jerrold Levy, MD
@JerroldLevy · X

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM https://t.co/NEiOC84MoP

May 15, 2021 · 1 share · 2,476 followers View post →